The process to develop new medicines stars with the identification of small molecules that can modulate a biological target or pathway associated to the disease. In the last twenty years Fragment Based Drug Discovery (FBDD) emerged as a successful alternative to conventional high throughput screening for the generation of chemical hits for drug targets. FBDD offers the advantage of covering larger amounts of chemical space with a relatively small number of different compounds.
Recruitment for our Wellcome 4-Year PhD Programme in Integrated molecular, cellular and translational biology is now open. Greater than 40 different supervisors participate with diverse research areas. Further information can be found on the programme website. Students on this programme will carry out three short laboratory placements prior to selection of main PhD project.